Valuation: Bould Opportunities PLC

Market Cap 5.71K 4.95K 4.64K 4.23K 7.96K 544K 8.08K 54.69K 21.31K 272K 21.43K 20.96K 909K P/E 2019
-0.01x
P/E 2020 -0.02x
Enterprise Value -78.29K -67.92K -63.68K -58.01K -109K -7.46M -111K -750K -292K -3.74M -294K -288K -12.47M EV / Sales 2019
-
EV / Sales 2020 -
Free-Float
76.48%
Yield 2019 *
-
Yield 2020 -
Manager TitleAgeSince
Director of Finance/CFO 65 14/05/2021
Chief Tech/Sci/R&D Officer 61 02/01/2025
Director TitleAgeSince
Director/Board Member 45 29/01/2019
Chairman 70 21/05/2019
Director/Board Member 61 14/05/2021
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+24.32% - - 3.54M
+0.91%+3.37%+15.04%+118.94% 10.62B
+2.94%+13.69%+315.24%+242.06% 2.71B
+0.20%+1.93%-30.48%-42.08% 2.1B
-1.34%-3.42%-10.47%-12.32% 1.88B
+0.61%-0.80%-23.57%-9.65% 979M
-1.90%-2.02%+31.76%+89.44% 879M
-1.08%+1.95%+57.08%+20.00% 779M
+1.95%+17.62%+49.04%+113.62% 715M
+0.18%+15.93%+65.03% - 649M
Average +0.25%+3.85%+52.07%+65.00% 2.13B
Weighted average by Cap. +0.71%+1.48%+49.56%+95.49%

Financials

2019 2020
Net sales - -
Net income -832K -722K -677K -616K -1.16M -79.31M -1.18M -7.97M -3.11M -39.72M -3.12M -3.06M -133M -306K -265K -249K -227K -427K -29.17M -433K -2.93M -1.14M -14.61M -1.15M -1.12M -48.75M
Net Debt -378K -328K -307K -280K -527K -36.03M -535K -3.62M -1.41M -18.05M -1.42M -1.39M -60.22M -84K -72.88K -68.32K -62.24K -117K -8.01M -119K -805K -314K -4.01M -315K -308K -13.38M
Logo Bould Opportunities PLC
Cizzle Biotechnology Holdings PLC is a United Kingdom-based diagnostics developer of early cancer tests. The Company is focused on early detection of lung cancer via the development of an immunoassay test for the CIZ1B biomarker. CIZ1B is a variant of CIZ1, a naturally occurring cell nuclear protein involved in protecting deoxyribonucleic acid (DNA). Its CIZ1B biomarker detects lung cancer at its earliest and most treatable stage. It is designed as a simple blood test, which enables early diagnosis before symptoms appear-when treatment options can transform outcomes for patients and families.
Employees
-